Search
+
    SEARCHED FOR:

    NOTE 800 TABLET

    Apple iPad mini OLED Review: The iPod Touch of 2026, and Perhaps the Best iPad for Most Users

    Apple iPad mini OLED review: With an 8.5-inch OLED display, A20 Pro chip and compact design, Apple's latest tablet brings back the spirit of the iPod Touch. But with the iPhone Duo offering a foldable screen, does the Rs 82,900 iPad mini still make sense? We review its display, performance, battery life and everyday usability to find out why it could be the most practical iPad for many users.

    Cancer drug prices fell in 2019 too, but mark-ups of up to 700% are back

    The government's latest cancer drug price cuts may offer patients some relief, but the impact could be short-lived. An analysis of medicines covered in the 2019 exercise found that mark-ups had risen to as much as 700% by 2026, raising questions about whether one-time price cuts can keep cancer treatment affordable.

    CashKaro data shows how Indians shopped this festive season: Smarter savings and growth beyond metros

    CashKaro data from six days of festive sales shows GMV up about 18x over a comparable regular period. Small cities, Telegram groups and smart shoppers stacking savings helped drive the surge, as fashion and electronics outpaced mobiles.

    ASUS Pad Review: A Welcome Comeback with Clear Compromises

    The ASUS Pad makes a comeback in India, showcasing a stunning premium display and a sleek, lightweight design. Its outstanding OLED panel enhances your entertainment experience. Yet, the device is powered by a mid-range processor, which may restrict demanding creative tasks. ASUS hasn't provided clarity on future software updates. While it's excellent for binge-watching, competing devices bring more processing power to the table.

    Dr Reddy's, Lupin recall products in US due to manufacturing issues

    Dr Reddy's Laboratories and Lupin are recalling products in the US due to manufacturing issues, according to the USFDA. Dr Reddy's is recalling Ibuprofen tablets for failing impurity specifications, while Lupin is recalling Cefixime for Oral Suspension due to subpotency. Both recalls are classified as Class II, indicating potential temporary or medically reversible adverse health consequences.

    Aurobindo Pharma gets USFDA nod for HIV drug

    Darunavir tablets, 600 mg and 800 mg, in combination with other antiretroviral agents, are indicated for the treatment of HIV-1 infection in adult and pediatric patients 3 years of age and older.

    The Economic Times
    BACK TO TOP
    Advertisement